We are live on ! Find out more
CVS icon

CVS Health

1,563 hedge funds and large institutions have $92.4B invested in CVS Health in 2016 Q1 according to their latest regulatory filings, with 101 funds opening new positions, 697 increasing their positions, 621 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $578M | Put options by funds: $368M

38% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 73

20% more funds holding in top 10

Funds holding in top 10: 200239 (+39)

12% more repeat investments, than reductions

Existing positions increased: 697 | Existing positions reduced: 621

3% more capital invested

Capital invested by funds: $90B → $92.4B (+$2.45B)

1% more ownership

Funds ownership: 83.5%84.5% (+1%)

1% more funds holding

Funds holding: 1,5551,563 (+8)

Holders
1,563
Holders Change
+8
Holders Change %
+0.51%
% of All Funds
41.64%
Holding in Top 10
239
Holding in Top 10 Change
+39
Holding in Top 10 Change %
+19.5%
% of All Funds
6.37%
New
101
Increased
697
Reduced
621
Closed
73
Calls
$578M
Puts
$368M
Net Calls
+$211M
Net Calls Change
+$165M
Name Holding Trade Value Shares
Change
Change in
Stake
DMIC
401
Dixon Mitchell Investment Counsel
British Columbia, Canada
$14.3M +$7.89M +81,193 +143%
ANI
402
American National Insurance
Texas
$14.2M -$48.6K -500 -0.4%
VWM
403
Valley Wealth Managers
New Jersey
$14.2M +$207K +2,130 +2%
Daiwa Securities Group
404
Daiwa Securities Group
Japan
$14M +$2.19M +22,500 +20%
RT
405
Rockland Trust
Massachusetts
$13.9M -$91.3K -939 -0.7%
CCM
406
Covington Capital Management
California
$13.8M +$926K +9,527 +8%
CBOA
407
Commonwealth Bank of Australia
Australia
$13.8M +$419K +4,310 +3%
AAM
408
Aureus Asset Management
Massachusetts
$13.6M +$166K +1,705 +1%
LIM
409
Lathrop Investment Management
Arkansas
$13.6M +$36.9K +380 +0.3%
WCP
410
Welch Capital Partners
New York
$13.6M +$478K +4,912 +4%
VC
411
Vestor Capital
Illinois
$13.6M +$262K +2,693 +2%
QIM
412
Quest Investment Management
Oregon
$13.5M -$1.16M -11,979 -8%
BFM
413
Boston Financial Management
Massachusetts
$13.5M -$289K -2,974 -2%
SAM
414
Shell Asset Management
Netherlands
$13.5M -$195K -2,007 -2%
BAM
415
Baring Asset Management
United Kingdom
$13.4M +$2.47M +25,399 +24%
PWAG
416
Polaris Wealth Advisory Group
California
$13.4M +$3.86M +39,707 +44%
VCM
417
Vigilant Capital Management
Maine
$13.3M -$605K -6,220 -5%
MA
418
MUFG Americas
New York
$13.3M -$354K -3,640 -3%
CCM
419
Catawba Capital Management
Virginia
$13.3M +$277K +2,849 +2%
JIR
420
James Investment Research
Ohio
$13.3M -$4.81M -49,462 -28%
MOACM
421
Mutual of America Capital Management
New York
$13.1M +$261K +2,685 +2%
Northwestern Mutual Wealth Management
422
Northwestern Mutual Wealth Management
Wisconsin
$12.9M +$880K +9,054 +8%
AT
423
Arden Trust
Delaware
$12.8M +$307K +3,162 +3%
WHG
424
Westwood Holdings Group
Texas
$12.8M +$83.3K +857 +0.7%
OC
425
Oppenheimer & Co
New York
$12.8M +$5.07M +52,141 +73%

CVS Hedge Fund Activity: Q1 2016 in Review

1,563 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2016, worth a combined $92.4B — up 2.7% from $90B a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new CVS positions and 73 closed out — a net gain of 28 holders — while 697 added to existing stakes and 621 trimmed.

The largest buyer was Royal London Asset Management, adding an estimated $2.69B. The largest seller was Wellington Management Group, cutting an estimated $884M.

  • 1,563 institutional investors held CVS Health (CVS) as of Q1 2016, up from 1,555 in Q4 2015.
  • Funds reported $92.4B of CVS Health stock for Q1 2016, up 2.7% quarter-over-quarter.
  • 101 funds opened new CVS Health positions in Q1 2016 and 73 closed out, a net change of +28 holders.
  • The largest CVS Health buyer in Q1 2016 was Royal London Asset Management, an estimated $2.69B added.
  • The largest CVS Health seller in Q1 2016 was Wellington Management Group, an estimated $884M sold.

Based on aggregated 13F filings for Q1 2016.